Delivery Order SPE2DB22D2206-SPE2DB25FGN46

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $28,143.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, covering the supply of XARELTO 20 MG TABLET 90S, a prescription medication used for cardiovascular conditions. The contract has an ultimate completion date of November 13, 2024. This award is associated with a larger Indefinite...
This federal contract award, valued at $7,124.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of February 11, 2025 and a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award, valued at $13,743.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product, with a Firm Fixed Price pricing type. The contract has an Ultimate Completion Date of June 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $27,050.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product, with a completion date of July 18, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is a delivery order valued at $43,156.71, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Xarelto 20 mg tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,527.10, is a delivery order for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 12, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,146.65 with a firm fixed-price pricing type and an ultimate completion date of December 20, 2024. The contract provides for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $45,656.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XARELTO 20 MG TABLET 90S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.15 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at $999,999,999, which provides a comprehensive range of...
This federal contract award, valued at $56,461.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of December 3, 2024. The contract covers the procurement of 4566584032 units of XARELTO 20 MG TABLET 90S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGN46
    Delivery Order

This federal contract award, valued at $15,942.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of XARELTO 20 MG TABLET 90S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has a firm fixed price and an ultimate completion date of April 14, 2025. The contract was not set aside for any specific business type.

Generated 7/11/25, 10:01 AM